Pretransplant donor-specific antibodies detected by single-antigen bead flow cytometry are associated with inferior kidney transplant outcomes

Transplantation

Volumn 90, Issue 10, 2010, Pages 1079-1084

  Singh, Neeraj ^a,b   Djamali, Arjang ^c   Lorentzen, David ^b   Pirsch, John D ^b,c   Leverson, Glen ^b   Neidlinger, Nikole ^b   Voss, Barbara ^b   Torrealba, Jose R ^b   Hofmann, R Michael ^c   Odorico, Jon ^b   Fernandez, Luis A ^b   Sollinger, Hans W ^b   Samaniego, Milagros ^c,d  

^a OHIO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

^d UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Antibody mediated rejection; High immunologic risk; Single antigen bead flow cytometry

Indexed keywords

ALEMTUZUMAB; CALCINEURIN INHIBITOR; CREATININE; CYCLOSPORIN; MYCOPHENOLIC ACID; PREDNISONE; PROTEIN; TACROLIMUS;

ADULT; ANTIBODY DETECTION; ANTIBODY MEDIATED REJECTION; ARTICLE; CREATININE BLOOD LEVEL; FEMALE; FLOW CYTOMETRY; GLOMERULUS FILTRATION RATE; GRAFT REJECTION; GRAFT SURVIVAL; HAZARD RATIO; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT; MAJOR CLINICAL STUDY; MALE; ORGAN DONOR; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN URINE LEVEL; PROTEINURIA; SINGLE ANTIGEN BEAD FLOW CYTOMETRY;

ADULT; ANTIBODY SPECIFICITY; FEMALE; GLOMERULAR FILTRATION RATE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; ISOANTIBODIES; KAPLAN-MEIER ESTIMATE; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; TISSUE DONORS; TREATMENT OUTCOME;

EID: 78650369432     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181f6a07b     Document Type: Article

References (15)

1. Colombo MB, Haworth SE, Poli F, et al. Luminex technology for anti-HLA antibody screening: Evaluation of performance and of impact on laboratory routine. Cytometry B Clin Cytom 2007;72:465.
2. Muro M, Llorente S, Marin L, et al. Acute vascular rejection mediated by HLA antibodies in a cadaveric kidney recipient: Discrepancies between Flow PRA, ELISA and CDC vs luminex screening. Nephrol Dial Transplant 2005;20:223.
3. El-Awar N, Lee J, Terasaki PI. HLA antibody identification with single antigen beads compared to conventional methods. Hum Immunol 2005;66:989.
4. Aubert V, Venetz JP, Pantaleo G, et al. Low levels of human leukocyte antigen donor-specific antibodies detected by solid phase assay before transplantation are frequently clinically irrelevant. Hum Immunol 2009;70:580.
5. Vlad G, Ho EK, E RV, et al. Relevance of different antibody detection methods for prediction of antibody mediated rejection and deceased-donor kidney allograft survival. Hum Immunol 2009;70:589.
6. Eng HS, Bennett G, Tsiopelas E, et al. Anti-HLA donor-specific antibodies detected in positive B-cell crossmatches by Luminex predict late graft loss. Am J Transplant 2008;8:2335.
7. Amico P, Honger G, Mayr M, et al. Clinical relevance of pretransplant donor-specific HLA antibodies detected by single-antigen flow-beads. Transplantation 2009;87:1681.
8. Burns JM, Cornell LD, Perry DK, et al. Alloantibody levels and acute humoral rejection early after positive crossmatch kidney transplantation. Am J Transplant 2008;8:2684.
9. Gebel HM, Bray RA, Nickerson P. Pre-transplant assessment of donor-reactive, HLA-specific antibodies in renal transplantation: Contraindication vs risk. Am J Transplant 2003;3:1488.
10. Morris GP, Phelan DL, Jendrisak MD, et al. Virtual crossmatch by identification of donor-specific anti-human leukocyte antigen antibodies by solid-phase immunoassay: A 30-month analysis in living donor kidney transplantation. Hum Immunol 2010;71:268.
11. Patel AM, Pancoska C, Mulgaonkar S, et al. Renal transplantation in patients with pre-transplant donor-specific antibodies and negative flow cytometry crossmatches. Am J Transplant 2007;7:2371.
12. van den Berg-Loonen EM, Billen EV, Voorter CE, et al. Clinical relevance of pretransplant donor-directed antibodies detected by single antigen beads in highly sensitized renal transplant patients. Transplantation 2008;85:1086.
13. Gupta A, Iveson V, Varagunam M, et al. Pretransplant donor-specific antibodies in cytotoxic negative crossmatch kidney transplants: Are they relevant? Transplantation 2008;85:1200.
14. Stevens LA, Coresh J, Greene T, et al. Assessing kidney function-measured and estimated glomerular filtration rate. N Engl J Med 2006;354:2473.
15. Solez K, Colvin RB, Racusen LC, et al. Banff 07 classification of renal allograft pathology: Updates and future directions. Am J Transplant 2008;8:753.